I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Herbaux, C
59
results:
Search for persons
X
Format
Online (59)
Mediatypes
Articles (Online) (48)
OpenAccess-fulltext (11)
Languages
english (45)
french (13)
Sorted by: Relevance
Sorted by: Year
?
1
Tafasitamab lenalidomide in relapsed/refractory large B‐cel..:
Paillassa, J.
;
Degoutte, C.
;
Oberic, L.
...
Hematological Oncology. 41 (2023) S2 - p. 591-592 , 2023
Link:
https://doi.org/10.1002/..
?
2
Cause of death and prognosis of patients (pts) with primary..:
Herbaux, C.
;
Dietrich, S.
;
McMillan, A.
...
Hematological Oncology. 41 (2023) S2 - p. 432-433 , 2023
Link:
https://doi.org/10.1002/..
?
3
Subgroup analysis of elderly patients (pts) with diffuse la..:
Hu, B.
;
Reagan, P. M.
;
Sehn, L. H.
...
Hematological Oncology. 41 (2023) S2 - p. 416-418 , 2023
Link:
https://doi.org/10.1002/..
?
4
Tandem versus single haematopoietic stem cell transplant an..:
Marouf, A.
;
Molinari, N.
;
Sibon, D.
...
British Journal of Haematology. 202 (2023) 2 - p. 379-383 , 2023
Link:
https://doi.org/10.1111/..
?
5
Pola‐R‐CHP versus R‐CHOEP in young patients with high‐risk ..:
Lenz, G.
;
Tilly, H.
;
Ziepert, M.
...
Hematological Oncology. 41 (2023) S2 - p. 420-421 , 2023
Link:
https://doi.org/10.1002/..
?
6
Long term follow‐up of untreated/relapsing MCL patients wit..:
Le Gouill, S.
;
Morschhauser, F.
;
Chiron, D.
...
Hematological Oncology. 41 (2023) S2 - p. 478-479 , 2023
Link:
https://doi.org/10.1002/..
?
7
KILT: A RANDOMIZED NON‐COMPARATIVE PHASE II LYSA STUDY OF L..:
Cheminant, M.
;
Carras, S.
;
Bruneau, J.
...
Hematological Oncology. 41 (2023) S2 - p. 838-839 , 2023
Link:
https://doi.org/10.1002/..
?
8
P1190: OUTCOMES BY BCL2 AND MYC EXPRESSION AND REARRANGEMEN..:
Morschhauser, F.
;
Jiang, Y.
;
Jardin, F.
...
HemaSphere. 6 (2022) - p. 1076-1077 , 2022
Link:
https://doi.org/10.1097/..
?
9
P1133: SUB-CUTANEOUS RITUXIMAB INDUCTION FOLLOWED BY SHORT ..:
Cartron, G.
;
Bachy, E.
;
Tilly, H.
...
HemaSphere. 6 (2022) - p. 1023-1024 , 2022
Link:
https://doi.org/10.1097/..
?
10
P844: CHARACTERIZATION OF MULTIPLE MYELOMA CELL LINES WITH ..:
De Boussac, H.
;
Machura, A.
;
Steer, A.
...
HemaSphere. 6 (2022) - p. 738-739 , 2022
Link:
https://doi.org/10.1097/..
?
11
ATEZOLIZUMAB + OBINUTUZUMAB + VENETOCLAX IN PATIENTS WITH R..:
Cartron, G.
;
Bachy, E.
;
Guidez, S.
...
Hematological Oncology. 39 (2021) S2 - p. , 2021
Link:
https://doi.org/10.1002/..
?
12
Correction to: Risk of relapse after anti-PD1 discontinuati..:
Manson, G.
;
Brice, P.
;
Herbaux, C.
...
European Journal of Nuclear Medicine and Molecular Imaging. 48 (2021) 5 - p. 1699-1700 , 2021
Link:
https://doi.org/10.1007/..
?
13
PROSPECTIVE EVALUATION OF LYMPHOMA RESPONSE TO IMMUNOMODULA..:
Al Tabaa, Y.
;
Casasnovas, O.
;
Baillet, C.
...
Hematological Oncology. 39 (2021) S2 - p. , 2021
Link:
https://doi.org/10.1002/..
?
14
A WIDE T‐CELL EXHAUSTION PATTERN IS FREQUENTIN THE TUMOR MI..:
Laurent, C
;
Syrykh, C
;
Herbaux, C
...
Hematological Oncology. 39 (2021) S2 - p. , 2021
Link:
https://doi.org/10.1002/..
?
15
ATEZOLIZUMAB + OBINUTUZUMAB + VENETOCLAX IN PATIENTS WITH R..:
Herbaux, C.
;
Schiano de Colella, J. M.
;
Thieblemont, C.
...
Hematological Oncology. 39 (2021) S2 - p. , 2021
Link:
https://doi.org/10.1002/..
1-15